Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC70
TNBC
Basal A
Trastuzumab
HER2
ErbB
9501.026
uM
7.09240
7.60970
0.4779 -0.2089 4.9603 0.0540
0.7273
0.7616
MDA-MB-415
HR+
Luminal
Cetuximab
EGFR
ErbB
9664.124
uM
inf
inf
0.9407 0.9407 0.0000 -0.0184
0.0798
0.8433
MDA-MB-453
TNBC
Luminal
Cetuximab
EGFR
ErbB
7903.042
uM
inf
inf
0.9956 0.9956 0.0000 -0.0024
-0.0113
1.1508
HCC1187
TNBC
Basal A
Cetuximab
EGFR
ErbB
7811.018
uM
inf
inf
0.6946 0.6946 0.0000 0.1308
-0.0060
0.4694
HCC1187
TNBC
Basal A
Cetuximab
EGFR
ErbB
7812.042
uM
inf
inf
0.5614 0.5614 0.0000 0.0267
0.3674
0.9722
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
9146.122
uM
inf
inf
0.9694 0.9694 0.0000 -0.0404
-1.9847
1.3408
MDA-MB-415
HR+
Luminal
Cetuximab
EGFR
ErbB
7897.018
uM
inf
inf
0.8611 0.8611 0.0000 0.0755
-0.1097
0.8448
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7793.018
uM
inf
inf
0.9318 0.9318 0.0000 0.0067
0.3477
1.3186
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
9035.018
uM
inf
inf
0.9083 0.9083 0.0000 0.0297
0.4162
2.1555
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7794.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
1.6812
MDA-MB-134-VI
HR+
Luminal
Trastuzumab
HER2
ErbB
10077.026
uM
7.0350
7.93710
0.4622 -0.4084 4.9480 -0.0133
0.9348
0.3999
MCF7
HR+
Luminal
Cetuximab
EGFR
ErbB
9583.026
uM
inf
inf
0.9966 0.9966 0.0000 0.0156
-0.0344
1.2731
MCF 10F
NM
-
Pertuzumab
7487.102
mg/ml
inf
124.94960
0.6533 -0.1750 0.2135 0.1284
0.7894
1.5273
MCF 10A
NM
Basal B
Cetuximab
EGFR
ErbB
7870.018
uM
0.39912
0.12872
0.4513 0.4038 1.4562 0.0600
0.9769
2.2478
MCF 10A
NM
Basal B
Cetuximab
EGFR
ErbB
9551.026
uM
inf
0.14350
0.7282 0.7281 4.9914 0.0090
0.9280
2.6508
MCF 10F
NM
-
Trastuzumab
HER2
ErbB
9566.026
uM
inf
inf
0.9681 0.9681 0.0000 -0.0233
-0.7310
2.1367
HCC70
TNBC
Basal A
Cetuximab
EGFR
ErbB
9501.026
uM
inf
0.01283
0.4925 0.5840 1.2619 0.0978
0.8957
0.7616
HMT-3522 S1
Unknown
Unknown
Cetuximab
EGFR
ErbB
7911.018
uM
0.02673
0.01835
0.1964 0.1241 0.7579 0.2589
0.9901
1.8543
HCC38
TNBC
Basal B
Trastuzumab
HER2
ErbB
10268.122
uM
3.49450
1.70630
0.4865 0.4861 4.9935 0.0343
0.6574
0.6345
MCF7
HR+
Luminal
Cetuximab
EGFR
ErbB
7874.018
uM
inf
inf
0.9611 0.9611 0.0000 -0.0261
-0.1994
1.6506
HCC70
TNBC
Basal A
Cetuximab
EGFR
ErbB
7860.042
uM
1.41750
6.04060
0.6742 -0.9996 0.7577 0.0164
0.8799
0.6736
SUM185PE
TNBC
Luminal
Cetuximab
EGFR
ErbB
7921.042
uM
inf
inf
1.0399 1.0399 0.0000 -0.0494
-236.5755
0.6355
SUM185PE
TNBC
Luminal
Cetuximab
EGFR
ErbB
10146.124
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.9296
HCC70
TNBC
Basal A
Cetuximab
EGFR
ErbB
7857.042
uM
inf
0.00139
0.7456 0.7944 5.0000 0.1040
0.8457
1.1910
HCC70
TNBC
Basal A
Cetuximab
EGFR
ErbB
7856.018
uM
inf
inf
0.8811 0.8811 0.0000 0.0121
0.4683
0.9388